// company-profile
Acrivon Therapeutics, Inc. Insider Trading
ACRVEvery SEC Form 4 insider trading filing for Acrivon Therapeutics, Inc. (ACRV) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=ACRV" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
Recent insider activity is bearish. Over the last 30 days, insiders net sold $3K across 2 transactions.
// 90-day insight
Over the last 90 days, Acrivon Therapeutics, Inc. insiders bought $0 (22 transactions) and sold $33K (9 transactions).
- Most active insider: Blume-Jensen Peter with 5 transactions totaling $28K.
- Largest single sale: $25K by Blume-Jensen Peter on May 21, 2026.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Acrivon Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Levy Adam D. | ACRV | Sale | 1,142 | $1.57 | $2K |
| Jul 21, 2026 | Miller Mary | ACRV | Sale | 573 | $1.76 | $1K |
| Jun 17, 2026 | Shacham Sharon | ACRV | Award | 20,275 | $0.00 | $0K |
| Jun 17, 2026 | DiRocco Derek | ACRV | Award | 20,275 | $0.00 | $0K |
| Jun 17, 2026 | TOMSICEK MICHAEL JOHN | ACRV | Award | 20,275 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →